Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral liquid for treating polycystic ovarian syndrome

A polycystic ovary and syndrome technology, applied in sexual diseases, drug combinations, medical preparations containing active ingredients, etc. therapeutic effect

Inactive Publication Date: 2014-02-26
苏宏英
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, although the existing traditional Chinese medicine compositions for the treatment of polycystic ovary syndrome have certain curative effects, there are defects such as insufficiently significant curative effect and low safety to varying degrees, so they need to be used in conjunction with western medicine, and the dosage form is still based on decoction. Lord, it is inconvenient to take and carry

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Weigh the following raw materials by weight: 25 parts of dodder, 20 parts of amethyst, 15 parts of rehmannia, 15 parts of Eupatorium, 15 parts of Ligustrum lucidum, 15 parts of Eucommia ulmoides, 10 parts of Schisandra chinensis, 10 parts of Atractylodes macrocephala, Semen psyllium 10 parts, 5 parts of Duhuo, 5 parts of Astragalus, 5-10 parts of Cistanche, and 5-10 parts of Dilong.

[0031] Prepare Chinese medicine oral liquid as follows:

[0032] (1) Weigh and mix the raw materials according to the parts by weight, add 10 times the weight of distilled water and soak for 8 hours, then decoct three times, the first decoction is 30 minutes, the second decoction is 25 minutes, and the third decoction 10 minutes;

[0033] (2) Combine the decoction, filter, and concentrate under reduced pressure until each milliliter of decoction is equivalent to 1 gram of raw material medicine;

[0034] (3) Add an appropriate amount of xylitol to the decoction, sterilize and subpackage t...

Embodiment 2

[0036] Weigh the following raw materials in parts by weight: 30 parts of dodder, 25 parts of amethyst, 20 parts of rehmannia, 20 parts of Eupatorium, 20 parts of Ligustrum lucidum, 20 parts of Eucommia, 15 parts of Schisandra chinensis, 15 parts of Atractylodes macrocephala, Semen psyllium 15 parts, 10 parts of Duhuo, 10 parts of Astragalus, 10 parts of Cistanche, and 10 parts of Earthworm.

[0037] Prepare Chinese medicine oral liquid as follows:

[0038] (1) Weigh and mix the raw materials by weight, add 10 times the weight of distilled water and soak for 8 hours, decoct three times, the first decoction for 30 minutes, the second decoction for 25 minutes, the third decoction 10 minutes;

[0039] (2) Combine the decoction, filter, and concentrate under reduced pressure until each milliliter of decoction is equivalent to 1 gram of raw material medicine;

[0040] (3) Add an appropriate amount of xylitol to the decoction, sterilize and subpackage to obtain the oral liquid of t...

Embodiment 3

[0042] Weigh the following raw materials in parts by weight: 22 parts of dodder, 22 parts of amethyst, 18 parts of rehmannia, 18 parts of Eupatorium, 18 parts of Ligustrum lucidum, 18 parts of Eucommia ulmoides, 12 parts of schisandra, 12 parts of Atractylodes macrocephala, Semen psyllium 12 parts, 7 parts of Duhuo, 7 parts of Astragalus, 7 parts of Cistanche, and 7 parts of Dilong.

[0043] Prepare Chinese medicine oral liquid as follows:

[0044] (1) Weigh and mix the raw materials by weight, add 10 times the weight of distilled water and soak for 8 hours, decoct three times, the first decoction for 30 minutes, the second decoction for 25 minutes, the third decoction 10 minutes;

[0045] (2) Combine the decoction, filter, and concentrate under reduced pressure until each milliliter of decoction is equivalent to 1 gram of raw material medicine;

[0046] (3) Add an appropriate amount of xylitol to the decoction, sterilize and subpackage to obtain the oral liquid of the prese...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oral liquid for treating polycystic ovarian syndrome. The oral liquid is prepared from the following raw materials in parts by weight: 25-30 parts of semen cuscutae, 20-25 parts of fluoritum, 15-20 parts of radix rehmanniae recen, 15-20 parts of herba lycopi, 15-20 parts of glossy privet fruit, 15-20 parts of eucommia ulmoides, 10-15 parts of Chinese magnoliavine fruit, 10-15 parts of rhizoma atractylodis macrocephalae, 10-15 parts of semen plantaginis, 5-10 parts of radix angelicae pubescentis, 5-10 parts of astragalus membranaceus, 5-10 parts of cistanche deserticola and 5-10 parts of lumbricus. The oral liquid has principle effects of tonifying the kidney and invigorating the spleen, reinforcing kidney and removing stasis, invigorating the blood circulation and clearing damp, and has excellent curative effect on a patient suffering from polycystic ovarian syndrome in the clinical situation.

Description

technical field [0001] The invention relates to a Chinese patent medicine, in particular to an oral liquid for treating polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common disease among adolescents and reproductive women, and its incidence has been on the rise in recent years. One of its pathophysiological changes is insulin resistance and androgen excess, leading to persistent ovarian anovulation, and a series of metabolic syndromes such as postprandial hyperglycemia, hyperlipidemia, hypertension and coronary heart disease. The main clinical manifestations of polycystic ovary syndrome are amenorrhea, oligomenorrhea and functional bleeding, which account for 70%-80% of women with abnormal menstruation, account for 30% of secondary amenorrhea, and account for anovulatory functional bleeding. 85% of patients with polycystic ovary syndrome have ovulatory dysfunction and lack of periodic progesterone secretion. The endometrium i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/804A61K9/08A61P15/08A61K35/56A61K33/14A61K35/62
Inventor 苏宏英
Owner 苏宏英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com